Literature DB >> 27703037

Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.

Xiaolu Xiong1, Jun Jiao1, Anthony E Gregory2, Pengcheng Wang1,3, Yujing Bi1, Xiaoyi Wang1, Yongqiang Jiang1, Bohai Wen1, Daniel A Portnoy4, James E Samuel2, Chen Chen4.   

Abstract

Coxiella burnetii is a gram-negative bacterium that causes acute and chronic Q fever. Because of the severe adverse effect of whole-cell vaccination, identification of immunodominant antigens of C. burnetii has become a major focus of Q fever vaccine development. We hypothesized that secreted C. burnetii type IV secretion system (T4SS) effectors may represent a major class of CD8+ T-cell antigens, owing to their cytosolic localization. Twenty-nine peptides were identified that elicited robust CD8+ T-cell interferon γ (IFN-γ) recall responses from mice infected with C. burnetii. Interestingly, 22 of 29 epitopes were derived from 17 T4SS-related proteins, none of which were identified as immunodominant antigens by using previous antibody-guided approaches. These epitopes were expressed in an attenuated Listeria monocytogenes vaccine strain. Immunization with recombinant L. monocytogenes vaccines induced a robust CD8+ T-cell response and conferred measurable protection against C. burnetii infection in mice. These data suggested that T4SS effectors represent an important class of C. burnetii antigens that can induce CD8+ T-cell responses. We also showed that attenuated L. monocytogenes vaccine vectors are an efficient antigen-delivery platform that can be used to induce robust protective CD8+ T-cell immune responses against C. burnetii infection.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD8+ T-cell epitopes; Q fever; antigen presentation; protective immunity; type IV secretion system effector

Mesh:

Substances:

Year:  2017        PMID: 27703037      PMCID: PMC6281342          DOI: 10.1093/infdis/jiw470

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

Review 1.  Q fever.

Authors:  Neil R Parker; Jennifer H Barralet; Alan Morton Bell
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

2.  Australia's national Q fever vaccination program.

Authors:  Heather F Gidding; Cate Wallace; Glenda L Lawrence; Peter B McIntyre
Journal:  Vaccine       Date:  2009-02-12       Impact factor: 3.641

3.  Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.

Authors:  Charles L Larson; Paul A Beare; Daniel E Voth; Dale Howe; Diane C Cockrell; Robert J Bastidas; Raphael H Valdivia; Robert A Heinzen
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

Review 4.  Antigenic analysis for vaccines and diagnostics.

Authors:  Laura R Hendrix; Chen Chen
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.

Authors:  Robert E Brennan; Kasi Russell; Guoquan Zhang; James E Samuel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 6.  Vaccines against Coxiella infection.

Authors:  Guoquan Zhang; James E Samuel
Journal:  Expert Rev Vaccines       Date:  2004-10       Impact factor: 5.217

7.  Balb/c mouse model and real-time quantitative polymerase chain reaction for evaluation of the immunoprotectivity against Q fever.

Authors:  Jingbo Zhang; Bohai Wen; Meiling Chen; Jun Zhang; Dongsheng Niu
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

8.  Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

Authors:  Dirk G Brockstedt; Martin A Giedlin; Meredith L Leong; Keith S Bahjat; Yi Gao; William Luckett; Weiqun Liu; David N Cook; Daniel A Portnoy; Thomas W Dubensky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

9.  Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.

Authors:  Guoquan Zhang; Kasi E Russell-Lodrigue; Masako Andoh; Yan Zhang; Laura R Hendrix; James E Samuel
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

10.  Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.

Authors:  Chen Chen; Courtney Dow; Peng Wang; John Sidney; Amanda Read; Allen Harmsen; James E Samuel; Bjoern Peters
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

View more
  11 in total

Review 1.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

Review 2.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  Rapid and Visual Detection of Coxiella burnetii Using Recombinase Polymerase Amplification Combined with Lateral Flow Strips.

Authors:  Yong Qi; Qiong Yin; Yinxiu Shao; Suqin Li; Hongxia Chen; Wanpeng Shen; Jixian Rao; Jiameng Li; Xiaoling Li; Yu Sun; Yu Lin; Yi Deng; Wenwen Zeng; Shulong Zheng; Suyun Liu; Yuexi Li
Journal:  Biomed Res Int       Date:  2018-04-12       Impact factor: 3.411

4.  Development of a rapid and visual detection method for Rickettsia rickettsii combining recombinase polymerase assay with lateral flow test.

Authors:  Yong Qi; Yinxiu Shao; Jixian Rao; Wanpeng Shen; Qiong Yin; Xiaoling Li; Hongxia Chen; Jiameng Li; Wenwen Zeng; Shulong Zheng; Suyun Liu; Yuexi Li
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

5.  Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Authors:  Anja Scholzen; Guilhem Richard; Leonard Moise; Laurie A Baeten; Patrick M Reeves; William D Martin; Timothy A Brauns; Christine M Boyle; Susan Raju Paul; Richard Bucala; Richard A Bowen; Anja Garritsen; Anne S De Groot; Ann E Sluder; Mark C Poznansky
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

6.  The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever.

Authors:  Venkatesh Kumaresan; Shawkat Alam; Yan Zhang; Guoquan Zhang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 7.  Preclinical Animal Models for Q Fever Vaccine Development.

Authors:  Mahelat Tesfamariam; Picabo Binette; Carrie Mae Long
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

8.  Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice.

Authors:  Changjiao Gan; Wenbo Luo; Yunzhou Yu; Zhouguang Jiao; Sha Li; Duo Su; Junxia Feng; Xiaodong Zhao; Yefeng Qiu; Lingfei Hu; Dongsheng Zhou; Xiaolu Xiong; Jinglin Wang; Huiying Yang
Journal:  NPJ Vaccines       Date:  2021-06-22       Impact factor: 7.344

9.  Analysis of recombinant proteins for Q fever diagnostics.

Authors:  Halie K Miller; Gilbert J Kersh
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.996

10.  Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling.

Authors:  P M Reeves; S Raju Paul; L Baeten; S E Korek; Y Yi; J Hess; D Sobell; A Scholzen; A Garritsen; A S De Groot; L Moise; T Brauns; R Bowen; A E Sluder; M C Poznansky
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.